CellFE Patents

Patent portfolio assigned to CellFE (verified via public assignee records). Estimated patent count: 3. Alameda/California cell-engineering company; microfluidic mechanoporation platform for cell-therapy manufacturing; $22M Series A (M Ventures). Patents confirmed assigned to CellFE, Inc. (e.g. WO2020232418A1 'Intracellular delivery', US20220213422A1, granted US12359158/US12227729). Strategic collaboration with DKFZ and its spin-out TcellTech.